A report from Jefferies highlighted that while a healthier population is likely to reduce insurance premiums, this would only be seen in new business
Market Momentum: Insights from a Global Thought Leader The global GLP-1 receptor agonist market is projected to exceed $100 billion by 2030, driven by dual indications in diabetes and weight loss
Nichols says
Perfusion 22(1):911 Escolar E, Lamas GA, Mark DB, Boineau R, Goertz C, Rosenberg Y, Nahin RL, Ouyang P, Rozema T, Magaziner A, Nahas R, Lewis EF, Lindblad L, Lee KL (2014) The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT)
This is especially significant because the pharmaceutical industry is currently shifting gears
Every prescription must include dosage, frequency, route of administration, and refill authorizationstate pharmacy boards audit this documentation during routine inspections